MFS Blended Research Mid Cap Equity Fund - Class I
$17.50
MFS Blended Research Mid Cap Equity Fund - Class I (BMSLX) Forecast
See the Price Targets and Ratings of:
BMSLX Analyst Rating
Moderate Buy
177ConsensusRatings
147Buy29Hold1Sell
Based on the Wall Street analyst consensus for 177 of BMSLX’s holdings.
BMSLX Analyst Price Target
Average Price Target
$21.05▲(20.30% Upside)
Based on Wall Street analyst 12-month price targets for 177 of MFS Blended Research Mid Cap Equity Fund - Class I’s holdings in the last 3 months. The average price target is $21.05 with a high forecast of $24.65 and a low forecast of $17.59. The average price target represents a 20.30% change from the last price of $17.50.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$24.65
Average$21.05
Low$17.59
Past 12 Months12 Month Forecast$13$16$19$22$25Feb2026May2026Aug2026Nov2026Nov2027
What is BMSLX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 177 of BMSLX’s holdings, MFS Blended Research Mid Cap Equity Fund - Class I’s 12-month average price target is $21.05.
What is BMSLX’s upside potential, based on the analysts’ average price target?
BMSLX’s average price target of $21.05 represents a 20.30% upside from its last price of $17.50.
Is BMSLX a Buy, Sell or Hold?
MFS Blended Research Mid Cap Equity Fund - Class I has a consensus rating of Moderate Buy, based on the analyst consensus for 177 of BMSLX’s holdings: 147 rated Buy, 29 rated Hold and 1 rated Sell.
What is MFS Blended Research Mid Cap Equity Fund - Class I’s price target?
The average price target for MFS Blended Research Mid Cap Equity Fund - Class I is $21.05, based on Wall Street analyst 12-month price targets for 177 of BMSLX’s holdings, issued in the past 3 months. The highest price target is $24.65 and the lowest is $17.59. The average price target represents a 20.30% increase from the last price of $17.50.
How can I buy shares of BMSLX?
You can buy shares of BMSLX through a brokerage account. Compare brokers on our Best Online Brokers page.